ASST Spedali Civili di Brescia
Brescia, 25123, Italy
NCT Number: NCT07598838
The study aims to evaluate the outcome of patients (overall survival) who received treatments commensurate with the proposed "Fitness" parameters compared to that of patients whose treatment differed either in the direction of greater or lesser aggressiveness than that proposed (evaluation of survival through Kaplan-Meier analysis and comparison with the log-rank test).
This study is active but is not currently recruiting participants.
65 year and older
All sexes
Observational
Brescia, 25123, Italy
Evaluate adherence to SIE/SIES/GITMO criteria in therapeutic choice: assess the treatment actually received by the different patient groups and any deviations from those proposed (descriptive statistics)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Acute Myeloid Leukemia Diagnosis no Acute Promyelocytic Leukemia aged more than 65 years
fitness categories and treatment received
Time frame: "From enrollment to the end of treatment at 12 months"
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Other
Multicenter Retrospective Observational Study to Verify the Application of SIE/SIES/GITMO FITNESS CRITERIA to Guide Therapeutic Choice in Elderly Patients With Acute Myeloid Leukemia in Light of the Availability of New Drugs - AML FITNESS
Acronym: AML-FITNESS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07297576
ALL (Acute B-Lymphoblastic Leukemia), AML (Acute Myelogenous Leukemia
Tianjing, China
View Trial DetailsNCT07254312
AML (Acute Myelogenous Leukemia, Hematologic Diseases
Pavia, Italy
View Trial DetailsNCT07254611
AML (Acute Myelogenous Leukemia, Hematologic Diseases
Pavia, Lombardy, Italy
View Trial DetailsNCT07014449
AML (Acute Myelogenous Leukemia, Adult Acute Myeloid Leukemia
Hangzhou, Zhejiang, China
View Trial Details